ID BC7 AC CVCL_1E03 DR BEI_Resources; ARP-11434 DR cancercelllines; CVCL_1E03 DR Wikidata; Q54795315 RX PubMed=8929542; RX PubMed=11264379; CC Population: Caucasian. CC Characteristics: CD4 negative. CC Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line). CC Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. CC Cell type: T-cell; CL=CL_0000084. DI NCIt; C7210; Childhood T lymphoblastic lymphoma DI ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_1714 ! SUP-T1 SX Male AG 8Y CA Cancer cell line DT Created: 08-07-15; Last updated: 19-12-24; Version: 16 CH CVCL_ZX81 ! BC7/CCR5 // RX PubMed=11264379; DOI=10.1128/JVI.75.8.3903-3915.2001; PMCID=PMC114881; RA Means, Robert E. RA Matthews, Thomas RA Hoxie, James A. RA Malim, Michael Henry RA Kodama, Toshiaki RA Desrosiers, Ronald Charles RT "Ability of the V3 loop of simian immunodeficiency virus to serve as a RT target for antibody-mediated neutralization: correlation of RT neutralization sensitivity, growth in macrophages, and decreased RT dependence on CD4."; RL J. Virol. 75:3903-3915(2001). // RX PubMed=8929542; DOI=10.1016/S0092-8674(00)81393-8; RA Endres, Michael J. RA Clapham, Paul R. RA Marsh, Mark RA Ahuja, Menaka RA Turner, Julie Davis RA McKnight, Aine RA Thomas, Jill F. RA Stoebenau-Haggarty, Beth RA Choe, Sunny RA Vance, Patricia J. RA Wells, Timothy Nigel Carl RA Power, Christine A. RA Sutterwala, Shaheen S. RA Doms, Robert W. RA Landau, Nathaniel R. RA Hoxie, James A. RT "CD4-independent infection by HIV-2 is mediated by fusin/CXCR4."; RL Cell 87:745-756(1996). //